SA
ALPMY logo
Astellas Pharma Inc.(ALPMY)
Closing price · checked 10:13 PM ETAbout this dataData status
$16.96▲0.06 (0.36%)
Pre-Market:$16.96+0.00 (+0.00%)· 10:13 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 22.1)

Overview →

Astellas Pharma Inc. (ALPMY)

EBITDA Margin

23.61%

TTM · Period ending:

ALPMY logo

ALPMY EBITDA Margin

Latest reported23.61%
ALPMY EBITDA Margin (17.91% → 23.61%)
High-resolution chart · PNG

What is ebitda margin?

EBITDA as a percentage of revenue.

ALPMY ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Astellas Pharma Inc. EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
28.198%
12.9709%
12.148%
16.2567%
18.6334%
17.6315%
24.1958%
24.0156%
21.8991%
26.4958%
24.2284%
20.7042%
16.487%
17.9093%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.